Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy

Vaccine

Volumn 29, Issue 51, 2011, Pages 9480-9487

  Pozza, Francesca ^a   Piovesan, Cinzia ^a   Russo, Francesca ^a   Bella, Antonino ^b   Pezzotti, Patrizio ^c   Emberti Gialloreti, Leonardo ^d  

^a Direction of Prevention   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Unit of Infecious Diseases and Vaccination   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autoregressive modelling; Hospital admissions; Surveillance; Vaccine; Varicella

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; DISEASE REGISTRY; DRUG EFFICACY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; ITALY; PEDIATRICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VACCINATION;

ADOLESCENT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HERPESVIRUS 3, HUMAN; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MASS VACCINATION; PATIENT ACCEPTANCE OF HEALTH CARE; REGIONAL MEDICAL PROGRAMS;

EID: 81955161884     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.022     Document Type: Article

References (34)

1. Aebi C., Fischer K., Gorgievski M., Matter L., Muhlemann K. Age-specific seroprevalence to varicella-zoster virus: study in Swiss children and analysis of European data. Vaccine 2001, 19:3097-3103.
2. Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 1996, 10:571-581.
3. Sengupta N., Booy R., Schmitt H.J., Peltola H., Van-Damme P., Schumacher R.F., et al. Varicella vaccination in Europe: are we ready for a universal childhood programme?. Eur J Pediatr 2008, 167:47-55.
4. Varilix. Summary of Product characteristics. Available online at: (accessed May 2011). http://www.gsk.com/products/vaccines/varilrix.htm.
5. Varivax. Available online at: (accessed May 2011). http://www.merckvaccines.com/Products/Varivax/Pages/VarivaxHome.aspx.
6. Seward J.F., Marin M., Vazquez M. Varicella vaccine effectiveness in the US Vaccination Program: a review. J Infect Dis 2008, 197:S82-S89.
7. Galil K., Brown C., Lin F., Seward J. Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J 2002, 21:931-934.
8. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002, 287:606-611.
9. Gao Z., Gidding H.F., Wood J.G., MacIntyre C.R. Modelling the impact of one-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiol Infect 2010, 138:457-468.
10. SPES (Sorveglianza Pediatri Sentinella). SPES Data, Risultati 2000-2008. (accessed May 2011). http://www.spes.iss.it/index.htm.
11. Knuf M., Neiss A., Wutzler P. Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis. Klin Padiatr 2006, 218:203-212.
12. Titone L., Giommanco G., Giommanco G.M. Universal varicella vaccination program in Sicily. Varicella vaccination in Europe. Proceedings of the 21st annual meeting of the european society for paediatric infectious diseases 2003.
13. Baldo V., Baldovin T., Russo F., Busana M.C., Piovesan C., Bordignon G., et al. Varicella: epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis 2009, 9:150.
14. ISTAT, Italian National Institute of Statistics (ISTAT). Resident Population. (accessed May 2011). http://www.demo.istat.it/.
15. Ciofi degli Atti M.L., Rota M.C., Mandolini D., Bella A., Gabutti G., Crovari P., et al. Assessment of varicella underreporting in Italy. Epidemiol Infect 2002, 128:479-484.
16. Zeileis A., Kleiber C., Kramer W., Hornik K. Testing and dating of structural changes in practice. Comput Stat Data Anal 2003, 44:109-123.
17. Zeileis A., Leisch F., Hornik K., Kleiber C., Strucchange: An R Package for testing for structural change in linear regression models. J Stat Softw 2002, 7:1-38.
18. Wei W.W.S. Time series anaylsis: univariate and multivariate methods 2006, Pearson Addison Wesley, Wesley.
19. Bonanni P., Breuer J., Gershon A., Gershon M., Hryniewicz W., Papaevangelou V., et al. Varicella vaccination in Europe - taking the practical approach. BMC Med 2009, 7:26.
20. Guris D., Jumaan A.O., Mascola L., Watson B.M., Zhang J.X., Chaves S.S., et al. Changing varicella epidemiology in active surveillance sites - United States, 1995-2005. J Infect Dis 2008, 197:S71-S75.
21. Reynolds M.A., Watson B.M., Plott-Adams K.K., Jumaan A.O., Galil K., Maupin T.J., et al. Epidemiology of varicella hospitalizations in the United States, 1995-2005. J Infect Dis 2008, 197:S120-S126.
22. Lerner-Geva L., Hirsh-Yechezkel G., Novikov I., Farkash H., Boyko V., Spirer Z., et al. The effect of active immunization on varicella-related hospitalizations in Israel. Hum Vaccin 2009, 5:1-5.
23. Bonanni P., Boccalini S., Bechini A., Banz K. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalized cases. Vaccine 2008, 26:5619-5626.
24. Zhou F., Harpaz R., Jumaan A.O., Winston C.A., Shefer A. Impact of varicella vaccination on health care utilization. JAMA 2005, 294:797-802.
25. Davis M.M., Patel M.S., Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004, 114:786-792.
26. Karhunen M., Leino T., Salo H., Davidkin I., Kilpi I., Auranen K. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect 2010, 138:469-481.
27. Kwong J.C., Tanuseputro P., Zagorski B., Moineddin R., Chan K.J. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?. Vaccine 2008, 26:6006-6012.
28. van Hoek A.J., Melegaro A., Zagheni E., Edmunds W.J., Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 2010, 29:2411-2420.
29. Arvin A.M. Humoral and cellular immunity to varicella-zoster virus: an overview. J Infect Dis 2008, 197:S58-S60.
30. Gabutti G., Penna C., Rossi M., Salmaso S., Rota M.C., Bella A., et al. The seroepidemiology of varicella in Italy. Epidemiol Infect 2001, 126:433-440.
31. Reynolds M.A., Chaves S.S., Harpaz R., Lopez A.S., Seward J.F. The impact of the varicella vaccination program on herpes zoster epidemiology in the united states: a review. J Infect Dis 2008, 197:S224-S227.
32. Carville K.S., Riddell M.A., Kelly H.A. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria. Aust Vaccin 2010, 28:2532-2538.
33. Alain S., Paccalin M., Larnaudie S., Perreaux F., Launay O. Impact de la vaccination de routine de l'enfant contre la varicelle sur l'épidémiologie du zona. Médecine et Maladies Infectieuses 2009, 39:698-706.
34. Emberti Gialloreti L., Merito M., Pezzotti P., Naldi L., Gatti A., Beillat M., et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010, 10:230.